Januvia, Janumet, Byetta, and Victoza are all pharmaceutical drugs used in the treatment of Type II diabetes. Studies have indicated that these drugs can drastically increase the risk of pancreatic cancer, one of the deadliest forms of cancer. Byetta users have also been shown to have an increased risk of thyroid cancer. At Hare Wynn, we have helped individuals and their family members fight for fair recovery to cope with the losses associated with these dangerous drugs. We understand how difficult it is to deal with the unexpected physical, emotional, and financial burdens that come with defective drug injuries, which is why we strive to provide each and every client with the compassionate, personalized attention they need and the tough, aggressive representation they deserve.
LEADERS IN DEFECTIVE DRUG LITIGATIONDa
Drug companies often prioritize profits over consumer safety. While they go on to make billions of dollars, consumers are left uninformed and vulnerable to the potential risks of these dangerous drugs.
- Januvia is an oral medication prescribed to control Type II diabetes in adults by lowering glucose levels.
- Janumet is an oral medication for diabetics who have not gained control of glucose levels from Januvia alone.
- Byetta lowers glucose levels and is administered via injection.
- Victoza, a twice-daily injection, was approved by the Federal Drug Administration (DA) in 2010.
Hare Wynn is heavily involved in litigation against pharmaceutical drug companies. We have expanded our complex litigation department to include claims against pharmaceutical companies, including one of the manufacturers of these drugs. Our dangerous and defective drug lawyers represent individuals and families who have been devastated by pancreatic cancer as a result of taking Januvia, Janumet, Byetta, and/or Victoza. If you or a loved one has taken one of these diabetes drugs and developed pancreatic cancer or, if after taking Byetta developed thyroid cancer, you may qualify for this litigation.